VipStockReports

Stocks in the News - MannKind Corporation (NASDAQ:MNKD), Cell Therapeutics Inc (NASDAQ:CTIC), Staples, Inc. (NASDAQ:SPLS), Amarin Corporation Plc (ADR)(NASDAQ:AMRN)

 
Repost This

Middletown, DE -- (SBWIRE) -- 09/18/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: MannKind Corporation (NASDAQ:MNKD), Cell Therapeutics Inc (NASDAQ:CTIC), Staples, Inc.(NASDAQ:SPLS), Amarin Corporation plc (ADR)(NASDAQ:AMRN)

MannKind Corporation (NASDAQ:MNKD) opened the session at $5.87, remained amid the day range of $5.75 - $5.90, and closed the session at $5.87. The stock showed a negative performance of -0.51% in previous trading session. The stock gained a volume of 6.19 million shares and the average volume of the stock remained 9.58 million shares. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.

Will MNKD Get Buyers Even After The Recent Rally? Find Out Here

Cell Therapeutics Inc (NASDAQ:CTIC) traded with volume of 8.96 million shares in the prior session and the average volume of the stock remained 1.08 million shares. The 52 week range of the stock remained $0.97 - $3.14. The stock showed a positive movement of +10.48% and closed its session at $1.37. The market capitalization of the stock remained 157.24 million. Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.

Will CTIC Continue To Move Higher? Find Out Here

Staples, Inc.(NASDAQ:SPLS) exchanged 5.76 million shares and the average volume remained 8.36 million shares. The stock escalated +1.36% and closed the session at $14.96. The beta of the stock remained 1.12 and the EPS of the stock remained -0.30. The shares outstanding of the stock remained 660.49 million. Staples, Inc., together with its subsidiaries, operates as an office products company. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations. The company offers various office supplies and services, office machines and related products, and office furniture under Staples, Quill, and other proprietary brands.

For How Long SPLS will fight for Profitability? Read This Trend Analysis report

Amarin Corporation plc (ADR)(NASDAQ:AMRN) gained volume of 5.33 million shares, while the average volume remained 4.84 million shares. The stock decreased -2.13% and finished the session Tuesday at $6.44. The EPS of the stock remained -0.92. The one month of the stock was +7.33% and three month trend remained negative -2.72%. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids.

Has AMRN Found The Bottom and Ready To Move Up? Find Out Here

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/